Wilson Disease
The DOI matches its Crossref record.
Abstract
Wilson disease is an inherited disorder of copper metabolism. Progress has been made in establishing the location of the gene on the long arm of chromosome 13, and in finding nearby probes that can be used to identify affected sibs of newly diagnosed patients. However, the gene has not been cloned, and the molecular nature of the defect remains unknown. The cause of the disease is a failure to excrete unneeded and excessive copper in the bile for loss in the stool. This may be due to a failure to excrete copper packaged in ceruloplasmin into the bile. Clinically, patients usually present during the second to fourth decades of life with liver, neurologic, or psychiatric disease, but the diagnosis is often missed or delayed. Once a diagnosis of Wilson disease is considered, reliable studies of copper variables can be carried out. After diagnosis, patients must receive anticopper treatment for the rest of their lives, to reduce copper levels and prevent copper reaccumulation. For life-long maintenance therapy, we recommend zinc acetate because of its complete efficacy and lack of toxicity; it acts by blocking copper absorption. For initial therapy of the acutely ill patient, no currently available therapy has proven to be ideal. A chelator-type drug, either penicillamine or trien, can be used for the initial therapy of patients who present with liver disease; transition to zinc acetate can then be made after a few months. For the initial therapy of acutely ill patients who prese…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Ninety percent of the Wilson's disease patients have low levels of ceruloplasmin, and ceruloplasmin-bound copper and nonceruloplasmin-bound copper are elevated in the plasma.”
From Discovery of Human Zinc Deficiency: Its Impact on Human Health and Disease (2013) · cites this paper as [65]
In the citing paper
“Patients typically present with liver disease, neurological disease (movement disorder), or psychiatric disturbances in the second to fourth decades of life. In many cases, the diagnosis is either missed or delayed (65, 66).”
From Discovery of Human Zinc Deficiency: Its Impact on Human Health and Disease (2013) · cites this paper as [65]
In the citing paper
“Wilson's disease is an inherited autosomal disorder of copper accumulation. The excretion of liver copper in the bile is decreased. This leads to failure of proper copper excretion in the stool and to the accumulation of copper in the liver. Eventually not only the liver but also brain and other organs are damaged due to excess copper accumulation.”
From Discovery of Human Zinc Deficiency: Its Impact on Human Health and Disease (2013) · cites this paper as [65]
In the citing paper
“This led Brewer et al. (65, 66) to develop zinc as an effective anticopper drug for Wilson's disease.”
From Discovery of Human Zinc Deficiency: Its Impact on Human Health and Disease (2013) · cites this paper as [65]
In the citing paper
“For maintenance therapy, zinc is the drug of choice (65, 66).”
From Discovery of Human Zinc Deficiency: Its Impact on Human Health and Disease (2013) · cites this paper as [65]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Still being checked.
Cited by
The Wilson disease gene is a putative copper transporting P–type ATPase similar to the Menkes gene
Bull, P. C., Thomas, G. R., Rommens, J. M., Forbes, J. R., & Cox, D. W. (1993) · Nature Genetics · doi:10.1038/ng1293-327 · Cited by 1,948
Copper biochemistry and molecular biology
Linder, M. C., & Hazegh-Azam, M. (1996) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/63.5.797 · Cited by 1,430
Discovery of Human Zinc Deficiency: Its Impact on Human Health and Disease
Prasad, A. S. (2013) · Advances in Nutrition · doi:10.3945/an.112.003210 · Cited by 919
AGA technical review on the evaluation of liver chemistry tests
Green, R. M., & Flamm, S. (2002) · Gastroenterology · doi:10.1053/gast.2002.36061 · Cited by 587
Rink, L. (2000) · Proceedings of the Nutrition Society · doi:10.1017/s0029665100000781 · Cited by 581
Metadata
- Authors
- BREWER, G. J., & YUZBASIYAN-GURKAN, V.
- Affiliations
- University of Michigan (US)
- Venue
- Medicine
- Published
- 1992-05
- Volume
- 71
- Issue
- 3
- Pages
- 139-164
- ISSN
- 0025-7974 (ISSN-L)
- OpenAlex
- W4242082702
- Cited by
- 303
- References
- 0
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 6 · 2023: 6 · 2022: 8 · 2021: 2 · 2020: 13 · 2019: 5 · 2018: 9 · 2017: 8 · 2016: 7 · 2015: 1 · 2014: 14 · 2013: 5 · 2012: 11
- FWCI
- 9.51
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Food and Drug Administration (FD-U-000505, FD-R-000179)
- National Center for Research Resources (M01RR000042)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Keywords
- Wilson's disease, copper metabolism, ATP7B, chromosome 13, ceruloplasmin, copper excretion, chelation therapy, D-penicillamine, triethylenetetramine, zinc acetate, tetrathiomolybdate, liver disease, neurological disorders, delayed diagnosis, gene cloning
- MeSH terms
- Hepatolenticular Degeneration, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Wilson Disease. https://app.cochat.ai/papers/10.1097/00005792-199205000-00004
- The paper
- BREWER, G. J., & YUZBASIYAN-GURKAN, V. (1992). Wilson Disease. Medicine. https://doi.org/10.1097/00005792-199205000-00004
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.